Latest Features
- Bacterial resistance to antibiotics is a global health threat. Creative collaboration is the key to successfully meeting the challenge.
- 17 November 2011
- Bacterial resistance to antibiotics is a global health threat. Creative collaboration is the key to successfully meeting the challenge.
- 17 November 2011
- If the pharmaceutical industry is to continue to improve global health outcomes, it must work in radically different ways
- 9 November 2011
- Leading pharmaceutical companies & research institutions offer IP and expertise for use in treating neglected tropical diseases
- 26 October 2011
- Dow Jones Sustainability Index ranks AstraZeneca among the industry leaders
- 11 October 2011
- Non-communicable diseases are on the increase. How are we helping to stem the tide?
- 19 September 2011
- AstraZeneca is donating $100,000 to the British Red Cross Pakistan Floods Appeal
- 4 August 2010
- How does a global company balance the need to drive business success with the needs of the environment?
- 4 June 2010
- Managing the waste we produce is another important feature of our environmental sustainability strategy.
- 3 June 2010
Key Facts
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.
We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
We employ over 61,000 people (46% in Europe, 24% in the North America, 7% in Latin America and 24% in Asia, Africa and Australasia).